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Carboxylic esterases are widely distributed in hematopoietic 
cells. Monocytes express the esterase isoenzyme (termed 
'monocyte-specific esterase', MSE) that can be inhibited by 
NaF in the a-naphthyl acetate cytochemical staining. We exam-
ined the expression of MSE in normal cells and primary and 
cultured leukemia-lymphoma cells. The MSE protein was dem-
onstrated by isoelectric focusing (IEF); MSE mRNA expression 
was investigated by Northern blotting and reverse tran-
scriptase-polymerase chain reaction (RT-PCR). The following 
samples were positive for MSE protein and Northern mRNA 
expression: 20/24 monocytic, 4/32 myeloid, and 1/20 erythroid-
megakaryocytic leukemia cell lines, but none of the 112 lymph-
oid leukemia or lymphoma cell lines; of the normal purified cell 
populations only the monocytes were positive whereas, T, B 
cells, and granulocytes were negative; of primary acute (myelo) 
monocytic leukemia cells (CD14-positive, FAB M4/M5 
morphology) 14/20 were Northern mRNA and 11/14 IEF protein 
positive. RT-PCR revealed MSE expression in 29/49 Northern-
negative lymphoid leukemia-lymphoma cell lines. The RT-PCR 
signals in monocytic cell lines were on average 50-fold 
stronger than the mostly weak trace expression in lymphoid 
specimens. On treatment with various biomodulators, only all-
trans retinoic acid significantly upregulated MSE message and 
protein levels but could not induce new MSE expression in sev-
eral leukemia cell lines; lipopolysaccharide and interferon-y 
increased MSE expression in normal monocytes. Analysis of 
DNA methylation with sensitive restriction enzymes showed no 
apparent regulation of gene expression by differential methyl-
ation; the MSE gene is evolutionarily conserved among mam-
malian species; the half-life of the human MSE transcripts was 
about 5-6 h. The extent of MSE expression varied greatly 
among different monocytic leukemia samples. However, the 
MSE overexpression in a significant number of specimens was 
not associated with gene amplification, gross structural 
rearrangements or point mutations within the cDNA region. 
Taken together, the results suggest that MSE expression is not 
absolutely specific for, but strongly associated with cells of the 
monocytic lineage; MSE is either not expressed at all or 
expressed at much lower levels in cells from other lineages. 
The biological significance, if any, of rare MSE messages in 
lymphoid cells detectable only by the hypersensitive RT-PCR 
remains unclear. Further studies on the regulation of this gene 
and on the physiological function of the enzyme will no doubt 
be informative with respect to its striking overexpression in 
some malignant cells and to a possible role in the pathobiology 
of monocytic leukemias. 
INTRODUCTION 
Esterases represent a diverse spectrum of enzymes w i th an 
ubiqu i tous tissue distr ibut ion that share certain features 
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regarding substrate spec i f ic i ty (1). These esterases be long to 
the class of serine hydrolases that are def ined as functional ly 
related hydro ly t i c enzymes con ta in ing a serine residue in their 
act ive site (2). This e n z y m e class compr ises the serine protease 
mul t igene fami ly as we l l as var ious carboxy l- , cho l in- , aryl-/ 
acetyl- and acety lchol inesterases (3). 
The carboxylesterases (EC 3.1.1.1) are a heterogeneous 
group of ce l lu la r enzymes capab le of h yd ro l yz i ng a variety ot 
a l iphat ic or aromat ic esters under a c id i c or neutral condit ions 
(4). In hemato logy these enzymes are k n o w n as non-specific 
esterases, act ing most eff ic ient ly on short-chain (acetate and 
butyrate) esters. The enzymat i c act iv i ty can be inhib i ted by 
sod ium f luor ide (NaF) in monocy t i c ce l ls , but not in cells 
of the granu locyt i c series (5); however , it shou ld be noted 
that NaF-resistance or sensit ivity is here c lear ly a relative 
p h e n o m e n o n (6). 
Nevertheless, the un ique substrate and inhib i tor specif icity 
of the esterase found in monocy tes ind ica ted early on that the 
high act iv i ty in monocy tes might be due to e n z y m e variants 
that are not present in other leukocytes (7). This not ion was 
strengthened by data f rom e lect rophoret ic analyses of enzyme 
extracts, first by po l yac r y l am ide gel e lectrophores is and later 
by isoelectr ic focus ing (IEF) ( reviewed in (8)). These zymogram 
IEF studies of normal and mal ignant mye l o i d ce l ls have con -
sistently demonstrated the existence of two ma in groups ot 
esterase bands. O n e group of IEF bands is c o m m o n to all 
mye lo id ce l ls (termed common esterase, ComEst , by Scott et 
al. (9)) and one is add i t iona l l y detected in cel ls of monocy t i c 
or ig in (termed monocyte-specific esterase, MSE). In the IEF 
analysis the ComEst group appears as a series of bands with 
isoeletr ic points (pl) ranging f rom 6.3-7.9 w h i l e MSE c o m -
prises 1-5 bands (depending on the IEF system used) w i th a 
nar row pl range 5.5-6.2 (3,9). 
For a long t ime it was not k n o w n whether ComEst and MSE 
be long to a mul t igene fami ly representing post-transcrip-
t iona l ly mod i f i ed variants of the same e n z y m e or whether they 
are c lear ly dist inct at the mo lecu l a r and genetic leve l , be ing 
related on ly in their substrate spec i f ic i ty (9). Recent exper-
imental ev idence supports the second v i ew , namely that C o m -
Est and MSE are unrelated e n z y m e spec ies : one appears to be 
a m o n o m e r i c acetylesterase and the other a tr imeric carboxy l-
esterase, respect ively (1,9). 
W e recently demonstrated the speci f ic i ty of MSE as 
express ion at the m R N A (examined by Northern blotting) and 
protein level (by IEF) were c lear ly restricted to ce l ls commi t ted 
to the monocy te-mac rophage l ineage (10). In order to sub-
stantiate these conc lus ions in a comprehens i ve survey and to 
further c lar i fy the nature of MSE , w e ana l yzed a greatly 
extended panel of pr imary and cont inuous l y cu l tured leuke-
m ia ce l ls app l y ing extremely sensit ive detect ion methods, 
exam ined the gene express ion under in vivo and manipu la ted 
in vitro cond i t ions , and character ized the MSE gene in 
further deta i l . 
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MATERIAL AND METHODS 
Primary Normal and Malignant Cell Material 
Fresh l eukemia ce l ls were taken from per iphera l b l o o d (PB) 
or bone mar row (BM) f rom patients w i th mye lo i d l eukemia of 
the morpho log i c a l M 4 or M 5 subtypes a c co rd ing to the 
French-Amer ican-Br i t i sh (FAB) c lass i f i ca t ion. Samples were 
sent to the reference laboratory of author W . D . L for immuno-
phenotype analys is . PB or B M mononuc l e a r cel ls were separ-
ated by standard F i c o l l - H y p a q u e density gradient centrifug-
ation ( Lymphoprep , N y c o m e d , O s l o , Norway ) . A l l samples 
Were exam ined w i th the f o l l o w i n g panel of surface markers 
using f l ow cytometry : C D 2 , C D 3 , C D 4 , C D 7 , C D 1 0 , C D 1 3 , 
C D 1 4 , C D 1 5 , C D 1 9 , C D 3 3 , C D 3 4 , C D 4 1 , C D w 6 5 , glyco-
phor in A , H L A - D R . Ce l l s were pel leted and frozen in l iqu id 
nitrogen. 
N o r m a l PB m o n o n u c l e a r ce l ls taken d i rect ly by venu-
puncture of laboratory staff or f rom buffy coats (generously 
prov ided by the G e r m a n Red Cross B l ood Transfusion Center , 
Springe, Germany ) were isolated by standard F i c o l l - H y p a q u e 
density gradient centr i fugat ion. The ce l ls were separated from 
the vast majority of thrombocytes by repeated low-speed sed i -
mentat ions (200 x g for 7 min) . M o n o n u c l e a r ce l ls were 
adjusted to 2-20 x 1 0 6 cel ls/ml w i th macrophage-serum free 
m e d i u m (M-SFM; G i b c o BRL, Eggenstein, Germany ) . Tissue 
cul ture dishes (Nunc , W i e s b a d e n , Germany ) conta in ing 1 0 -
15 ml of this ce l l suspens ion were incubated for 1 h at 37°C 
in a humid i f i ed incubator w i th 5 % C 0 2 . Non-adherent ce l ls 
were subsequent ly removed by wash ing the cul ture dishes 
repeatedly w i th w a r m phosphate-buffered sal ine (PBS) c o n -
ta in ing 0 . 5 % M-SFM. For R N A preparat ion ce l ls were washed 
from the dishes w i th g u a n i d i n i u m isothiocyanate. T cel ls were 
enr i ched by sheep red b l o o d ce l l rosetting ( ICN F low, Meck-
e n h e i m , Ge rmany ) . G ranu locy tes were co l l ec ted f rom the bot -
tom of the F i co l l gradient and separated from erythrocytes by 
a dextran gradient (Dextran T-500; Pharmac ia , Freiburg, 
Germany ) . N o r m a l B ce l ls were obta ined f rom surgica l ly 
removed tonsils after sheep red b l o o d ce l l rosetting of the 
mononuc l ea r ce l l preparat ion. The purit ies of the normal ce l l 
popu la t ions were ver i f ied by immunos ta in ing and f low cy to -
metr ic analysis ( FACScan ; Becton D i c k i n s o n , He ide lbe rg , 
Ge rmany ) : T cel ls were enr i ched to 9 7 % (CD3 + ), B cel ls to 
9 7 % ( C D 1 9 + ), monocy tes to 8 6 % ( C D 1 4 + and posit ive in 
the a-naphthyl acetate esterase c y tochemica l staining), and 
granulocytes to > 9 5 % (morpho log ica l analysis). In order to 
increase the quantity and the purity of ava i lab le normal m o n o -
cytes, monocy tes were isolated f rom mononuc l ea r ce l ls (after 
F i c o l l - H y p a q u e centrifugation) by counter-current e lutr iat ion 
(JGM-E Beckman centr i fuge; B e ckman , M u n c h e n , Germany ) 
us ing a large-volume chamber (50 ml) and a JE-5 rotor at 2 5 0 0 
r.p.m. and a f low rate of 110 ml/min in Hank ' s ba lanced salt 
so lut ion supp lemented w i th 2 % human a l b u m i n . Elutriated 
monocytes were > 9 5 % pure as determined by morpho logy 
and ant igenic phenotype . 
Culture of Cell Lines and In V i t r o Stimulation 
A l l human ce l l l ines were der ived f rom patients w i th l eukemia 
or l y m p h o m a (11). The cont inuous human and an ima l ce l l 
l ines were either taken f rom the stock of the ce l l bank ( D S M , 
G e r m a n C o l l e c t i o n of M i c roo rgan i sms and C e l l Cultures) (12) 
or were generously made ava i lab le for this study by the o r ig -
inat ing investigators. Ce l l s were g rown under opt ima l c o n -
di t ions in 50 ml or 2 6 0 ml tissue cul ture flasks or 24-wel l 
plates (Nunc) in their appropr iate med ia (RPMI 1640 , 
M c C o y ' s 5 A , Le ibowi tz ' s L-15, Iscove's M D M , D u l b e c c o ' s 
M E M , or M E M a lpha ; G i b c o BRL) supp lemented w i th 5 - 2 0 % 
heat-inactivated (at 56°C for 45 min) fetal bov ine serum 
(Sigma, De isenhofen , Germany ) at 37°C in a humid i f i ed 
atmosphere of 5 % C 0 2 in air. The cel ls were examined da i l y 
in the culture flasks under an inverted m ic roscope . Cultures 
were incubated wi thout ant ib iot ics in order to avo id sub l ima l 
bacter ia l in fect ion. O n l y mycoplasma-free cultures were used ; 
f reedom of m y c o p l a s m a contamina t ion was checked rout inely 
by DAP I staining and cul t ivat ion on agar. The cel ls were 
harvested in their logar i thmic growth phase w i th v iabi l i t ies 
exceed ing 9 0 % as determined by trypan b lue dye 
exc lus i on . C e l l pellets were kept f rozen at - 2 0 ° C or p ro -
cessed immedia te ly . 
In vitro s t imulat ion of ce l l l ines was carr ied out w i th two 
protein kinase C (PKC) activators, the pharmaco log i ca l 12-0-
tet radecanoy lphorbo l 13-acetate (TPA; Sigma) and the natural 
Bryostatin 1 (Bryo 1; k ind ly p rov ided by Prof G.R. Pettit, 
Tempe, A Z , USA) , the v i tamin A-analogue a\\-trans ret inoic 
ac id (ATRA; Sigma), and the c a l c i u m transport regulator 1,25-
d ihydroxyv i t amin D 3 (Vit. D 3 ; Sigma). The inducers were first 
d isso lved in ethanol or D M S O at 1 0 ~ * M and then further 
d i lu ted in RPMI 1640 m e d i u m so that the f inal concentrat ions 
of the solvent were max ima l l y 0 . 0 1 % in the exper iments . The 
cel ls were exposed to 1 0 ~ 7 M solut ions of the reagents for up 
to 4 days. PB monocytes and some ce l l l ines were st imulated 
wi th 100 ng/ml l ipopo lysacchar ide (LPS; Sigma) and 200 U/ml 
interferon-y (IFN-y; Boehr inger M a n n h e i m , M a n n h e i m , 
Germany ) for up to 24 h. 
RNA Isolation and Northern Blotting 
Total ce l lu la r R N A was isolated using the guan id in ium iso-
thiocyanate-ces ium ch lo r ide method (13). Northern blots 
were prepared by separating 10 /xg of total R N A in an agarose 
gel conta in ing 1 % formaldehyde . The R N A was transferred 
to a ny lon membrane (Nytran, Sch le icher and Schu l l , Dasse l , 
Germany ) and cross-l inked w i th 1200 J ultraviolet light (UV 
Stratalinker 1 8 0 0 ; Stratagene, He ide lbe rg , Germany ) . After 2 h 
of pre-hybr id izat ion the filters were hyb r id i zed w i th a nick-
translated (G ibco BRL) or random pr imed (USB, Bad H o m -
burg, Germany ) [«- } 2P]dCTP-labeled HMSE-1 probe overnight 
at 62°C. The filters were then washed stringently and exposed 
for autoradiography to X-ray f i lms (Fuji RX) w i th intensifying 
screens at - 8 0 ° C . Filters were rehybr id ized w i th a housekeep -
ing gene as the cont ro l . 
Probes 
A 1746-bp EcoRI fragment c l oned into p U C 1 9 conta in ing the 
partial c o d i n g sequence (nucleot ides - 1 0 to 1512 from the 
3'-end of the H M S E gene) was k ind ly p rov ided by D r F. 
Zschunke (Gott ingen, Germany ) (2). A 238-bp fragment of the 
HMSE-1 c D N A f rom the 5'-end (nt - 1 0 to 228 , obta ined after 
BamHl d igest ion and extract ion f rom the gel) was e m p l o y e d 
in some exper iments . The /3-actin probe pAct-1 , a 1.25-kb Pst\ 
fragment (c loned in pBR322) f rom the c D N A of hamster j8-
act in (obtained f rom Dr J .W .G . Janssen, U l m , Germany ) was 
used as con t ro l . 
Determination of RNA Half-Life 
The half-life of the MSE m R N A was determined by exposure 
of the cel ls to 10/Ltg/ml a c t i nomyc in D (Sigma), an inhibi tor 
of t ranscr ipt ion, for 0-24 h before harvest of the ce l ls and sub -
sequent isolat ion of R N A . 
Reverse Transcriptase-Polymerase Chain Reaction (RT-
PCR) 
Five mic rograms of total R N A was used as a template for first 
strand c D N A synthesis us ing a reverse transcriptase preampl i-
f icat ion system kit (Superscr ipt ; G i b c o BRL) in a f inal v o l u m e 
of 20 /il PCR buffer (conta in ing 20 m M Tris-HCI of p H 8.4, 
50 m M KCI , 2.5 m M M g C I 2 , 0.1 mg/ml BSA) supp lemented 
w i th 0.5 /Ag of o l i go dT pr imer . After heat ing the mixture at 
70°C for 10 m i n , 2 0 0 U of M o l o n e y mur ine l eukemia virus 
reverse transcriptase and 1 /LLI of 10 m M d N T P mix were added 
to the react ion system. The react ion mixture was then i n c u -
bated at 42 °C for 50 m i n , at 90 °C for 5 m in and then q u i c k l y 
ch i l l ed on ice. After brief centr i fugat ion, 2 U RNase H was 
added to the react ion mixture for 20 m in at 37°C. R N A 
samples f rom some ce l l l ines were treated w i th D N a s e I 
(RNase-free f rom Boehr inger M a n n h e i m ) pr ior to reverse t ran-
sc r ip t ion . The react ion was incubated at 37°C for 1 h and then 
at 95 °C for 5 m in and immed ia te l y c o o l e d on ice. Five 
microl i t res of the reverse transcriptase react ion mixture c o n -
ta in ing the first strand c D N A was d i lu ted w i th PCR buffer 
(10 X: 5 0 0 m M KCI , 15 m M M g C I 2 , 100 m M Tris-HCI p H 8.3, 
0 . 0 0 1 % gelatin) con ta in ing 20 p m o l of each upstream and 
downs t ream pr imer , 10 nmo l of d N T P mix and 1.25 U of Taq 
D N A po lymerase (Amersham-Buchler , B raunschwe ig , 
Ge rmany ) . The pr imers used in the exper iment were des igned 
a c c o r d i n g to sequence data pub l i shed prev ious ly (2): sense 5'-
G G C A G T T A C T C T C A G A G C T A - 3 ' (sequence nuc leot ides 9 2 -
1 1 1 , MSE-P1) and antisense 5 ' - C T T C C A C A G G A G T G A C -
A T G G C - 3 ' (sequence nuc leot ides 9 6 0 - 9 4 0 , MSE-P2). O l i g o -
nuc leo t ide pr imers were prepared on an automated D N A syn -
thesizer (Cy l cone Plus, M i l l i p o r e , Eschborn , Ge rmany ) . The 
PCR was then per formed w i th a D N A thermal cyc le r (Perkin 
Elmer Cetus, He ide lbu rg , Ge rmany ) for 32 cyc les under the 
f o l l o w i n g cond i t i ons : 30 s at 94 °C for denaturat ion , 30 s at 
55 °C for annea l ing , and 2 m i n at 72°C for extens ion . The 
amp l i f i ed PCR products were e lec t rophoresed in 1 . 2 % aga -
rose gels, stained w i th e th id ium b romide and observed under 
ultraviolet l ight. Ge l s were blotted onto ny lon filters us ing the 
Southern t echn ique as desc r ibed b e l o w . In order to assess the 
qual i ty of reverse t ranscr ibed R N A and successful PCR-ampl i-
f i ca t ion , a l iquots f rom the same products obta ined f rom 
reverse t ranscr ipt ion were amp l i f i ed in para l le l us ing the f o l -
l o w i n g two j3-actin pr imers : sense 5 ' - A T G G A T G A T G A T A -
T C G C C G C G - 3 ' and antisense 5 ' - C T A G A A G C A T T T G C G G T -
G G A C - 3 ' . 
Polymerase Chain Reaction and Single-Strand 
Conformation Polymorphism (PCR-SSCP) 
PCR-SSCP analys is was mod i f i ed f rom the prev ious desc r ip -
t ion (14). In brief, 6 /Ltl reverse t ranscr ibed c D N A was a m p l i -
f ied by PCR (30 cyc l es ; the same cond i t i ons as under RT-PCR) 
in the presence of 10 fid [ a- 3 2 P ]dCTP us ing the two pr imers 
MSE-P1 and MSE-P2 (see above) . F rom the ampl i f i ca t ion pro -
duct 4 /LLI were d i lu ted 1 : 25 w i th 0 . 1 % SDS , 10 m M E D T A 
and heated at 95 °C after add ing 1 v o l u m e sequenc ing stop 
so lut ion ( 9 5 % fo rmamide , 20 m M E D T A , 0 . 0 5 % b r o m o p h e n o l 
b lue , 0 . 0 5 % xy lene c y a n o l , 20 m M N a O H ) . Then , 2-4 /il of 
this mixture was loaded onto a 6 % non-denatur ing po lyacry l-
am ide gel con ta in ing 9 0 m M Tris-borate, 2 m M E D T A (pH 8), 
and 1 0 % g l yce ro l . E lectrophoresis was per formed at 25 W for 
4 h w i th air c o o l i n g . Subseqent ly the gel was dr ied and 
exposed to an X-ray f i lm for autorad iography overnight at 
room temperature. 
DNA Sequencing 
RT-PCR products were pur i f ied us ing Jetsorb ( G e n o m e d , Bad 
O e y n h a u s e n , Ge rmany ) . RT-PCR products were sequenced 
us ing the Taq DyeDeoxy™ Terminator C y c l e Sequenc ing Kit 
(App l i ed Biosystems, Weiterstadt, Ge rmany ) . The primers 
used were MSE-P1 as sense, antisense 5 ' - G G T T C T T G G C C A A -
T G G A G A C A - 3 ' (sequence nuc leot ides 5 2 6 - 5 0 6 , MSE-P3), 
antisense 5 ' - G G C T G G A T C T T C A T T C A C A G C - 3 ' (sequence 
nuc leot ides 1 5 2 6 - 1 5 0 6 , MSE-P4), and MSE-P2 as antisense at 
a concent ra t ion of 4 p m o l per sequence react ion. The sequ -
enc ing was per formed wi th the D N A thermal cyc le r for 25 
cyc les under the f o l l o w i n g cond i t i ons : 30 s at 96 °C for denat-
urat ion, 15 s at 50°C for annea l ing , and 4 m in at 60 °C for 
extens ion . The sequence react ions were pur i f ied as descr ibed 
by the manufacturer . The sequence react ions were e l ec t roph -
oresed us ing the A p p l i e d Biosystem's 3 7 3 A D N A Sequencer . 
Southern Blotting 
H i g h mo lecu l a r we ight D N A was extracted f rom f rozen PBS-
washed l eukemic ce l ls us ing standard methods (13). For the 
different exper iments 20 /ig of D N A was digested overnight 
w i th 1 0 0 U of one of the restrict ion enzymes HindlW 
(Pharmac ia , Fre iburg, Germany ) , #amHI, EcoRI, Pst\ (G ib co 
BRL), M s p l , /-/pall, or Cfo\ (Boehringer M a n n h e i m ) . To 1/10 
of the react ion mix 2 0 0 ng l ambda D N A (Pharmacia) was 
added as con t ro l . The digested D N A was extracted w i th phe -
no l , prec ip i tated in e thanol and separated in a 0 . 7 % agarose 
ge l . The D N A was f ixed w i th 0.2 N HCI and then denatured 
w i th 0.5 M N a O H / 1 . 5 M NaC I . After neutra l izat ion w i th 0.5 M 
Tris-HCI (pH 7.0)/3 M NaCI the D N A was blotted w i th 
20 x SSC on ny lon membranes and then treated and 
hyb r id i zed as desc r ibed above under Nor thern blot analys is . 
Pulsed Field Gel Electrophoresis 
Pulsed f ie ld gel e lectrophores is (PFGE) is an e lec t rophoret ic 
t echn ique alternative to standard Southern analysis that uses 
alternat ing pulses of current d i rected at angles through an aga-
rose gel to separate large D N A restrict ion fragments. Digested 
g e n o m i c D N A was separated on a 1 . 5 % agarose gel us ing the 
Chef-Dr II PFGE system (Bio-Rad, M u n c h e n , Germany ) 
a c co rd ing to the r ecommenda t ions of the manufacturer . In 
brief, the gel was run for 5 h at 14°C app l y ing a 2 0 0 V 
invert ing f ie ld . The sw i t ch ing c yc l e increased f rom 1 to 4 s 
over these 5 h. F o l l o w i n g PFGE the gel was treated s imi la r ly 
to a standard Southern blot . 
Isoelectric Focusing 
Enzyme extract ion, separat ion by IEF and v i sua l i za t ion of 
esterase i soenzymes have been descr ibed in detai l e l sewhere 
(10). In brief, enzymes were extracted by repeated cyc les of 
f reez ing-thawing and so lub i l i z ed by add i t ion of Tr i ton X 100 
(Serva, He ide lbe rg , Ge rmany ) . After centr i fugat ion, a l iquots of 
supernatant con ta in ing the e n z y m e preparat ion (extracted 
f rom equa l numbers of cells) were separated by ana ly t ica l IEF 
on hor izonta l thin-layer po l yac r y l am ide gels ( 4 . 8 % acry l/ 
b i sac ry l amide , p H range 2-11 of the ampho ly te Servalyt; 
Serva) using an LKB M u l t i p h o r system (Pharmacia) . Iso-
enzymes were v i sua l i zed on the gels by submers ion in a sta in-
ing so lu t ion con ta in ing a-naphthyl acetate (Sigma) as substrate 
and Fast B lue RR (Serva) as the c o u p l i n g d i a z o n i u m salt. 
A d d i t i o n of 4 0 m M NaF to the sta ining bath inh ib i ted se lec -
t ively the MSE band at about p H 6.0 (3). Bands on autoradio-
graphed R N A f i lms after Nor thern blot analysis or RT-PCR 
Southern blott ing and on dr ied IEF gels were quant i f ied densi-
tometr ica l ly (LKB U l t roscan Dens i tometer ; Pharmacia ) . 
RESULTS 
Expression of MSE 
Detection of Protein by IEF and of mRNA by Northern Blot-
ting. MSE protein was demonstrated by IEF on po lyacry l-
amide gels as a dist inct band w i th an isoeletr ic point of about 
p H 6.0. This band c o u l d be se lect ive ly inh ib i ted by NaF . In 
the Nor thern blot analysis a s ingle band co r respond ing to an 
MSE transcript of 2.0 kb was detected. Expression of MSE pro -
tein and m R N A were e x a m i n e d in al l samples , i.e. norma l ce l l 
popu la t ions , pr imary l eukemia ce l ls , and l eukemia ce l l l ines, 
by IEF and Nor thern blot t ing, respect ively (Tables 1 and 2; 
Figures 1 and 2). 
O f the pur i f ied normal ce l l popu la t ions {n= 10 f rom differ-
ent ind iv idua ls ) , on l y the PB monocy te preparat ions consist -
ent ly d i sp layed MSE protein and m R N A , whereas PB T ce l ls , 
PB granulocytes , and tonsi l lar B cel ls were al l negative. 
Twenty-two PB or B M acute (mye lo )monocyt i c l eukemia 
samples, d iagnosed as such on morpho log i c a l - c y tochem i ca l 
(FAB M 4 or M 5 ) and immunopheno t yp i c a l grounds ( C D 1 4 + ) , 
were tested. m R N A express ion was found in 14/20 cases 
tested; 11/14 cases ana l yzed showed the MSE band in the IEF. 
MSE express ion was exam ined in 188 ce l l l ines (Table 2). 
A l l 112 l y m p h o i d l eukemia and l y m p h o m a ce l l l ines were 
negative at the Nor thern m R N A and protein level (29 pre B-
ce l l l eukemia , 17 B-cell l eukemia , 21 T-cell l eukemia , 13 
m y e l o m a , 8 Burkitt, 8 H o d g k i n , and 16 non-Hodgk in l y m -
p h o m a ce l l l ines). In the category 'mye lo id l eukemia ce l l 
l ines ' {n = 32) four and five ce l l l ines were MSE-posit ive in the 
IEF and Nor thern analysis , respect ively. O n e out of 20 ce l l 
l ines w i th megakaryocy t i c and/or erythroid features showed 
the MSE bands in the IEF and Northern gels. The MSE iso-
e n z y m e and the MSE transcript were found in 20/24 ce l l l ines. 
Detection of mRNA by RT-PCR. To assess the detect ion 
sensit ivity of the IEF, Nor thern and RT-PCR analysis, posit ive 
cel ls were d i lu ted w i th MSE-negative ce l ls . In pre l iminary 
exper iments w e showed that it was poss ib le w i th IEF to v is -
ua l i ze an MSE-posit ive popu la t ion in a mixture cons is t ing of 
1 % posit ive ce l ls (cell l ine THP-1) and 9 9 % negative ce l ls 
(RC-2A). The d i lu t ion exper iments per formed here revealed 
that Nor thern blott ing had a max ima l sensit ivity of 2 . 5 % posi-
Table 1 Express ion of M S E m R N A and Prote in in P r imary H u m a n L e u k e m i a C e l l s 
Patient no. Surface Marker Express ion 3 FAB Subtype MSE Expression 
CD13 CD14 CD15 CD33 CDw65 Protein IEF b mRNA mRNA 
Northern 5 RT-PCR C 
1 70 56 31 90 80 M5 + + [2.89x] d 
2 10 5 75 35 70 M5 -
3 44 75 5 79 66 M4 ( + ) [0.71X]* 
4 50 70 70 90 87 M5 + [0.95x] + [0.55x] + 
5 75 60 37 76 60 M4eo -6 24 34 20 76 20 M4 + [1.24x] 
7 24 40 30 60 68 M4 ( + ) [0.1 Ox] 
8 12 52 44 20 80 M5a - - -
9 82 55 47 81 49 M5 - - -
10 71 85 11 85 83 M4 + [1.01x] + [1.06x] 
11 37 34 26 83 63 M4 ( + ) [0.59x] ( + ) [0.40x] + 
12 6 44 34 56 56 M5 ( + ) [0.70x] ( + ] [0.25x] + 
13 34 69 16 75 76 M5a - - + 14 34 47 20 80 86 M5b + [1.19x] + 
15 30 55 12 80 80 M4 + + [4.43x] ( + ) [0.24x] + 
16 37 62 0 36 52 M4 ( + ) [0.37x] ( + ) [0.36x] 
17 82 70 13 70 45 M4eo + [0.48x] 
18 34 60 14 90 72 M4eo ( + ) [0.61x] ( + ) [0.1 Ox] 
19 82 47 48 71 35 M4eo ( + ) [0.08x] 
20 21 19 32 73 66 M4/M5 -
21 14 33 77 82 87 M5 + + [6.22x] + + [5.61x] 
22 16 57 23 50 70 M5 + + [5.74x] + [0.18x] 
Express ion of these surface markers (percentage of positive cells) was examined by indirect immunofluorescence staining and either 
microscopic or flow cytometric analysis using the monoclonal antibodies My7 (CD13), VIM-13 or UCHM1 (CD14), VIM-D5 (CD15), My9 
(CD33), VIM-2 (CDw65); other markers examined are not listed but confirmed the diagnosis. 
"Intensity of bands on IEF gels and Northern gels; the intensity of expression (thickness of the band) was graded in comparison with those 
from normal control monocyte samples: -, negative; ( + ), weaker; +, same intensity; + + , overexpression (stronger band), 
intensity of bands on Southern gels hybridized with the HMSE-1 probe after RT-PCR: -, negative; +, positive. 
intensity of expression (thickness of bands in IEF and Northern) analyzed densitometrically in comparison with normal unstimulated mono-
cytes; data are given as X-fold of the normal values. 
Cell Line Or ig in 3 Protein mRNA 
IEF" Northern" RT-PCR C 
Pre-B Leukemia Cell Lines 
1 1E8 Pre B-ALL - -
2 207 Pre B-ALL - - + 
3 380 ALL - - ( + ) 
4 697 Pre B-ALL - - -
5 ALL-1 Pre B-ALL - -
6 BAY-91 ALL - - -
7 BV-173 CML-BC - - -
8 EU-1 ALL - -
9 HAL-01 Pre B-ALL - - ( + ) 
10 HPB-NULL ALL - -
11 KARPAS-353 Pre B-ALL - -
12 KOPN-8 ALL - -
13 LAZ-221 ALL - -
14 LILA-1 Pre B-ALL - -
15 LK-63 Pre B-ALL - -
16 MIK-ALL Pre B-ALL - -
17 NALM-1 CML-BC - -
18 NALM-6 ALL - - ( + ) 
19 NALM-16 ALL - -
20 OM9;22 ALL - -
21 PC-53 Pre B-ALL - - -
22 PRE-ALP Pre B-ALL - -
23 RCH-ACV Pre B-ALL - -
24 REH ALL - - + 
25 RS4;11 ALL - - + 
26 SUP-B15 Pre B-ALL - -
27 SUP-B27 Pre B-ALL - -
28 TAHR-87 AUL - -
29 TOM-1 Pre B-ALL — — 
B Leukemia Cell Lines 
1 BALL-1 ALL - -
2 BALM-1 B-ALL - -
3 BALM-6 B-ALL - -
4 BALM-8 B-ALL - -
5 BONNA-12 HCL - - -
6 EH HCL - - ( + ) 
7 EHEB B-CLL - - + + 
8 ESKOL HCL - - -
9 HAIR-M HCL - -
10 HC-1 HCL - -
11 HK HCL - -
12 JVM-2 B-PLL - - + + 
13 JVM-3 B-PLL - -
14 JVM-13 B-PLL - - + 
15 KARPAS-231 B-ALL - -
16 MN-60 B-ALL - - -
17 WIEN-133 B-ALL — — 
T Leukemia Cell Lines 
1 BE-13 T-ALL - -
2 CCRF-CEM ALL - -
3 CML-T1 CML-BC - - -
4 DU-528 T-ALL - -
5 HPB-ALL T-ALL - -
6 JURKAT T-ALL - -
7 KE-37 T-ALL - -
8 LOUCY T-ALL - -
9 MDS C M M o L - -
10 MKB-1 AML - -
11 MOLT-3 ALL - - ( + ) 
12 MOLT-13 T-ALL - -13 MOLT-15 AMoL - -
14 MOLT-16 T-ALL - - ( + ) 
15 MOLT-17 T-ALL - -
16 MO-T HCL - -
Cell Line Or ig in 3 Protein mRNA 
I E P Northern" RT-PCR C 
T Leukemia Cell Lines 
(Continued,) 
17 MT-1 ATL - - ( + ) 
18 P12/ICHIKAWA ALL - -19 PEER T-ALL - - + 
20 PF-382 ALL - - -
21 SKW-3 CLL - - -
Myeloma Cell Lines 
1 EJM Myeloma - - -
2 IM-9 Myeloma - - -
3 KARPAS-620 Plasma cell leukemia - -4 KARPAS-707 Myeloma - - -
5 L-363 Plasma cell leukemia - - -
6 LP-1 Myeloma - -
7 MM-1 Myeloma - - -8 MM-S1 Myeloma - - ( + ) 
9 NCI-H929 Myeloma - - -
10 OPM-2 Myeloma - - -
11 U-266 Myeloma - -
12 U-1958 Plasma cell leukemia - -13 U-1996 Myeloma - - -f 
Burkitt Lymphoma Cell Lines 
1 BJAB Burkitt - -
2 CA-46 Burkitt - - ( + ) 
3 DAUDI Burkitt - - + 
4 DG-75 Burkitt - -
5 EB-1 Burkitt - -
6 NAMALWA Burkitt - -
7 NAMALWA-IPN.45 Burkitt - -
8 ROS-17 Burkitt - - + 
Hodgkin Lymphoma Cell Lines 
1 C O Hodgkin (nodular sclerosis) - -
2 HDLM-1 Hodgkin (nodular sclerosis) - -3 HDLM-2 Hodgkin (nodular sclerosis) - - ( + ) 
4 HDLM-3 Hodgkin (nodular sclerosis) - -
5 KM-H2 Hodgkin (mixed cellularity) - - -
6 L-428 Hodgkin (nodular sclerosis) - - + 7 L-540 Hodgkin (nodular sclerosis) - -
8 SUP-HD1 Hodgkin (nodular sclerosis) — — 
Non-Hodgkin Lymphoma Cell Lines 
1 DEL Malignant histiocytosis - -
2 DOHH-2 B NHL (immunoblastic) - -
3 HBL-1 B NHL (diffuse large cell) - -
4 HT-58 B NHL (centroblastic) - - ( + ) 
5 KARPAS-299 T NHL (histiocytic) - - + 
6 KARPAS-422 B NHL - - ( + ) 7 MC-116 B NHL (undifferentiated) - - + + 
8 MH-1 Malignant histiocytosis - - ( + ) 
9 PFI-285 T NHL - - -10 RL B NHL (undifferentiated) - -
11 SCC-3 NHL (diffuse large cell) - - -12 ST-4 T NHL (convoluted type) - - + 
13 SUP-T1 T NHL (lymphoblastic) - -
14 U-698-M B NHL (lymphoblastic) - -
15 WSU-NHL B NHL (histiocytic) - -
16 WSU-WM Waldenstrom — — + 
Myeloid Leukemia Cell Lines 
1 EM-2 CML-BC - - + 2 EM-3 CML-BC - ( + ) + 
3 EOL-1 AML-eosino + + 
4 EOL-3 AML-eosino + ( + ) + 
5 GDM-1 CML-BC - - -
6 GF-D8 AML M1 - - + + 
Cell Line Or ig in 3 Protein mRNA 
IEF" Northern" RT-PCR C 
Myeloid Leukemia Cell Lines (Continued,) 
7 GM-153 AML - - -
8 GM/SO CML-BC - -
9 HL-60 A M L M2 - - ( + ) 
10 HMC-1 Mast cell leukemia - - ( + ) 
11 KASUMI-1 A M L M2 - -
12 KBM-7 CML-BC - - + + 
13 KCL-22 CML-BC - - -
14 KG-1 A M L - - ( + ) 
15 KG-1A A M L - - ( + ) 
16 KMT-2 Umbilical cord blood - - ( + ) 
17 KOPM-28 CML-BC - - + + 
18 KU-812 CML-BC - - + 
19 KU-812F CML-BC - - + + + 
20 KY-821 A M L - - + + + 
21 KYO-1 CML-BC - - + + 
22 MOLM-6 CML-BC - -
23 MOLM-7 CML-BC - -
24 MOLM-8 CML-BC - - + 
25 MR-87 A M L - -
26 NB-4 A M L M3 ( + ) ( + ) 
27 OCI-AML-5 A M L - - ( + ) 
28 PL-21 A M L M3 + ( + ) + + 
29 TI-1 A M L M2 - - -
30 TS9;22 CML-BC - -
31 UCSD/AML-1 A M L - - + 
32 YS9;22 CML-BC - - + 
Monocytic Leukemia Cell Lines 
1 CTV-1 AML M5 - - + 
2 DD Histiocytic lymphoma - - + -»-
3 JOSK-I A M L M4 + + + + + + + + + 
4 JOSK-K AML M5 + + + + + + + 
5 JOSK-M CML-BC + + + + + + 
6 JOSK-S A M L M5 + + + + + + + + 
7 KBM-3 A M L M4 + + + + + + + 
8 KBM-5 CML-BC ( + ) + + + + + + 
9 ML-2 AML M4 ( + ) ( + ) 
10 MOBS-1 AMoL + + + + + + + 
11 MONO-MAC-6 AML M5 + + + + + + + + + 
12 MV4-11 A M L M5 ( + ) ( + ) + + + 
13 NOMO-1 AMoL + + + + + + 
14 OCI-AML-1 AML M4 - - + 
15 OCI-AML-2 A M L M4 + + + + + + 
16 OCI-AML-3 A M L M4 + + + + + + + 
17 PLB-985 A M L M4 + + 
18 RC-2A A M L M4 - -
19 RW-LEU-4 CML-BC + + + + + 
20 SKM-1 AMoL + + + + + + + + 
21 THP-1 A M L M5 + + + + + + + + + 
22 TK-1B A M L M4 + + + + + 
23 U-937 Histiocytic lymphoma ( + ) ( + ) 
24 X-376 A M L + + + + + + + + 
Megakaryocytic-Erythroid Leukemia Cell Lines 
1 CHRF-288-11 A M L M7 - - + + 
2 C M K A M L M7 - - + + + 
3 DAMI A M L M7 - - + 
4 F-36P A M L M6 - - + + 
5 F-36EGM A M L M6 - - + + 
6 HEL AML M6 - - ( + ) 
7 K-562 CML-BC - - + 
8 KMOE-02 A M L M6 - - ( + ) 
9 LAMA-84 CML-BC - - + + + 
10 M-07e AML M7 - - + + 
11 MB-02 A M L M7 - -
12 MEG-01 CML-BC - — ( + ) 
Cell Line Or ig in 3 Protein mRNA 
IEF" Northern" RT-PCR C 
Megakaryocytic-Erythroid Leukemia Cell Lines (Continued) 
13 M E G A L AML M7 - - + + 
14 MKPL-1 A M L M7 + 
15 MOLM-1 CML-BC - - + + 
16 0CI-M1 AML M6 + 
17 0CI-M2 A M L M6 - -
18 T-33 CML-BC 
19 TF-1 A M L M6 + 
20 UT-7 AML M7 + + + + + + + 
ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; AMoL, acute (myelo)monocytic leukemia; 
ATL, adult T-cell leukemia; AUL, acute undifferentiated leukemia; CLL, chronic lymphocytic leukemia; CML-
BC, chronic myeloid leukemia in blast crisis; CMMoL , chronic myelomonocytic leukemia; HCL, hairy cell 
leukemia; NHL, non-Hodgkin's lymphoma; PLL, prolymphocytic leukemia. 
a Cel l lines were assigned to the respective categories based on their origin and their phenotypic and func-
tional characteristics (e.g. surface markers, receptor gene rearrangements, expression of hemoglobin, etc.); 
original diagnoses (types and subtypes of malignancies) are given as far as indicated in the original publi-
cations (see also (11)). 
"Intensity of bands on IEF gels and Northern gels; the intensity of expression (thickness of the band) was 
graded in comparison with those from normal control monocyte samples: -, negative; ( + ), weaker; +, 
same intensity, + + , overexpression (stronger band); + + + , strong overexpression (very strong band), 
intensity of bands on Southern gels hybridized with the HMSE-1 probe after RT-PCR; -, negative; ( + ), 
weakly positive; +, + + , + + + , different degrees of positivity. 
tive ce l ls (PLB-985) in a backg round of 9 7 . 5 % negative cel ls 
(KG-1). RT-PCR was 5 0 - 2 5 0 t imes more sensit ive than N o r t h -
ern as the RT-PCR product of MSE was reproduc ib l y detect-
able at a 1 : 2 0 0 0 to 1 : 10 0 0 0 d i l u t i on . These results con f i rm 
s imi lar levels of sensit ivity in d i l u t ion exper iments done to 
detect the e n z y m e mye loperox idase ( M P O ) : 1 - 3 % for N o r t h -
ern and 0 . 0 5 - 0 . 1 % for RT-PCR (15). The more sensit ive RT-
PCR method was carr ied out, both to con f i rm the results 
obta ined by Nor thern blott ing, and to further character ize any 
trace express ion of ce l l l ines negative at the protein and 
Nor thern m R N A leve l . The RT-PCR generated a un ique and 
accurate ly s ized product of 8 6 8 bp. The identity of PCR pro -
ducts f rom the ce l l l ines was con f i rmed by Southern blots of 
the PCR products (Figure 3). The intensity of express ion shown 
by RT-PCR is, of course , a gross estimate and not an exact 
quant i f i ca t ion (since w e d i d not perform quantitat ive PCR), 
but prov ides nevertheless a c lear and reproduc ib le picture of 
MSE trace express ion . 
O n e hundred and fourteen ce l l l ines were examined for 
MSE m R N A express ion by RT-PCR using pr imers MSE-P1 
and -P2, f o l l o w e d by Southern blott ing and hybr id iza t ion wi th 
the HMSE-1 probe (Table 2). Seventy-two ce l l l ines were pos i -
t ive; upon s igni f icant ly longer exposure of the f i lms to the 
radioact ive filter a further 17 of the 42 in i t ia l ly negative ce l l 
l ines showed weak bands. O f the 49 Northern-negative 
l y m p h o i d l eukemia and l y m p h o m a ce l l l ines, 29 (59% ) were 
posi t ive, most of them weak l y or very weak l y . Systemic c o n -
taminat ions were exc l uded as negative cont ro l ce l l l ines and 
negative contro ls ( H 2 0 ) were consistent ly negative in al l 
exper iments ; furthermore, the results were con f i rmed in 24 
ce l l l ines us ing the pr imer pair MSE-P1 and -P3. N o part icular 
pattern of posit iv i ty or negativity was seen a m o n g the var ious 
categories. Eighteen of 22 Northern-negative mye lo id leuke -
m ia ce l l l ines d i sp layed bands in the RT-PCR Southern blots. 
A l l 21 monocy t i c ce l l l ines investigated were RT-PCR-posit ive 
i n c l ud ing four ce l l l ines that were both IEF- and Northern-
negative. W i t h one except ion al l samples (A? = 1 8 ) f rom ce l l 
cultures w i th megakaryocyt ic-erythro id features were N o r t h -
ern-negative, but RT-PCR-posit ive. Scann ing densi tometry of 
the RT-PCR Southern blots ind icated that MSE m R N A was 
approx imate ly 10-50-fo ld and 3-10-fold more abundant in 
monocy t i c ce l l l ines (e.g. JOSK-I, )OSK-K, jOSK-S, U-937) 
than in l y m p h o i d l eukemia (e.g. JVM-13 , N A L M - 6 , REH) and 
erythroid-megakaryocyt ic ce l l l ines (e.g. F-36P, L A M A - 8 4 , 
OC I-M1) , respect ively. 
Overexpression of MSE 
Prev iously , w e noted a str iking var iabi l i ty in the sta ining inten-
sity of the MSE protein band in the IEF a m o n g different m o n o -
cyt ic l eukemia samples w h i c h , however , was not ev ident in 
normal contro ls . C o m p a r e d wi th the bands f rom norma l PB 
monocy te popu la t ions a certain percentage of the l eukemic 
spec imens showed increased express ion of the i soenzyme . As 
ce l l extracts were prepared f rom the same number of cel ls 
and equa l amounts of m R N A (10 /ig) were app l i ed in the gels, 
w e compared the intensity of MSE , IEF, and Nor thern 
bands between normal and l eukemic samples by densito-
metric scann ing . 
Leukemia Cell Lines. The extent of MSE m R N A and p ro -
tein express ion var ied greatly a m o n g the 26 posit ive ce l l l ines. 
Nor thern blot and IEF analysis showed that the steady-state 
levels of MSE transcripts and i soenzyme bands were elevated 
in 16/26 (62% ) and in 9/25 (36% ) ce l l l ines, respect ively, re la -
t ive to norma l pur i f ied monocy tes (Figures 1, 2, 4, and 5). W e 
cons idered any abundant MSE express ion as 'overexpress ion ' 
w h e n cases showed in the dens i tometr ic scann ing at least 
tw ice the amount of Northern m R N A or IEF protein found in 
the norma l unst imulated monocytes . A c c o r d i n g to these c r i -
teria 16 ce l l l ines overexpressed MSE m R N A and n ine ce l l 
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Figure 1 A n a l y s i s of M S E m R N A exp ress ion in a pane l of l e u k e m i a ce l l l ines a n d n o r m a l PB m o n o c y t e s (Monos ) . Tota l c e l l u l a r R N A f rom 
the c e l l l ines i nd i c a t ed was a n a l y z e d by No r the rn b lo t t ing a n d h y b r i d i z e d w i t h the HMSE-1 c D N A p robe . The M S E message has a s i ze of 
2.0 kb . Inspect ion of the e t h i d i u m bromide-s ta ined gel c o n f i r m e d integrity of the R N A . H y b r i d i z a t i o n w i t h the /3-actin p robe w a s used as an 
interna l con t ro l for the l o a d i n g of s im i l a r a m o u n t s of R N A 
l ines overexpressed the prote in . The protein levels were not 
c lose ly related to m R N A levels in some ce l l l ines. The levels 
of protein express ion in seven ce l l l ines overexpress ing R N A 
message fell into the range of 8 0 - 2 0 0 % of that of norma l 
monocy tes . The intensities of the IEF bands of 16 ce l l l ines 
were in the range of 5 0 - 1 7 0 % of those of norma l monocy tes . 
L o w MSE express ion might be caused by def i c ienc ies at va r i -
ous levels, but are more l ike ly based on the relative i m m a -
turity of the ce l ls , i.e. ce l ls were arrested at deve lopmenta l 
stages where phys io log i ca l l y this gene product is not yet 
expressed. 
Primary Leukemia Cells. T w o out of the 14 (14% ) m R N A -
posit ive cases expressed MSE at levels that were 2.8-5.6-fold 
higher than the MSE m R N A levels found in norma l monocy tes 
(Table 1). A b n o r m a l l y h igh MSE protein levels were detected 
in 3/11 (27% ) MSE-posit ive l eukemic samples (range 4.4-6.2-
fold) (Table 1). 
Induced Expression of MSE 
Leukemia Cell Lines. In order to ana l yze whether MSE 
express ion can be modu la ted in vitro, posit ive and negative 
ce l l l ines were st imulated w i th A T R A , TPA , Vi t . D 3 or Bryo 1 
and LPS + IFN-y. A T R A upregulated steady-state levels of 
MSE transcripts in posi t ive ce l l l ines (n= 3); T P A was not very 
effective and either up- or downregu la ted , albeit on l y sl ightly, 
the m R N A and protein levels in posi t ive ce l l l ines (n = 4) 
(Table 3; Figures 6 and 7). Vi t . D 3 and Bryo 1 were not effec-
tive in al ter ing the MSE express ion , neither up- nor down-
regulat ion in posit ive ce l l l ines nor new l y i nduced express ion 
in negative ce l l l ines (HL-60, NB-4). LPS + IFN-y caused on l y 
minor , insignif icant changes ( < 2 5 % ) in MSE m R N A and p ro -
tein express ion in seven l eukemia ce l l l ines. Ne i ther A T R A , 
TPA , nor LPS + IFN-y induced new MSE transcripts or protein 
in the in i t ia l ly negative ce l l l ines HL-60, KG-1 , and TI-1. The 
morpho log i c a l appearance of ce l l l ines in w h i c h MSE 
express ion c o u l d not be i nduced or altered was, nevertheless, 
c lear ly mod i f i ed attesting to the e f f i c iency of the inducers 
Figure 2 Express ion of M S E pro te in in p r ima ry m o n o c y t i c l e u k e m i a samp les (a) a n d in l e u k e m i a ce l l l ines (b) in c o m p a r i s o n w i t h n o r m a l 
PB m o n o c y t e s (Monos ) . E n z y m e s w e r e ex t rac ted , s o l u b i l i z e d , separated by IEF o n p o l y a c r y l a m i d e gels a n d v i s u a l i z e d by a-naphthy l acetate 
s ta in ing . T h e M S E i s o e n z y m e is f o cused as a d is t inc t s ing le or d o u b l e b a n d at abou t p H 6.0 ( ind ica ted by arrows) . Th is b a n d c o u l d be se lec t i ve l y 
i nh ib i t ed by N a F (not shown ) . T h e g r o u p of IEF bands w i t h h igher i soe lec t r i c po ints (pH 6 . 3 - 7 . 9 , the uppe r bands in the figure) have been 
t e rmed common esterases ( C o m Est) (9), but are expressed i n d e p e n d e n t l y of the M S E i s o e n z y m e ; c o m p a r e for e x a m p l e i s o e n z y m e patterns of 
EOL-1 , EOL-3 , j O S K - l , a n d jOSK-K a n d pat ients #8, #12, a n d #13. EM-3 a n d pat ients #8 and #13 are c l ea r l y MSE-negat i ve . A l i q u o t s of e n z y m e 
extracts f r om equa l n u m b e r s of ce l l s w e r e separated by IEF. Thus , the intensity of the M S E bands c o u l d be c o m p a r e d re lat ive to the leve l o f 
exp ress ion by n o r m a l m o n o c y t e s 
used : adherence to the plast ic flask in TPA- or Bryo 1-exposed and PLB-985 cel ls in the presence of the transcr ipt ion inh ib i tor 
cul tures; en largement of the cy top lasma in TPA-, Bryo 1- or a c t i nomyc in D. The h of MSE m R N A was about 5-6 h. 
ATRA-treated ce l l s ; ce l lu la r aggregation in cultures w i th LPS. 
Normal Monocytes. Exposure of normal monocytes to LPS 
+ IFN-y enhanced both MSE m R N A and protein levels by a 
factor of 1.5-2. Cu l ture in serum-free m e d i u m (M-SFM) w i th 
or w i thout A T R A showed a downregu la t i on of MSE m R N A 
express ion in norma l monocy tes to 2 0 % at 48 h, 1 % at 72 h 
and 0 . 3 % at 96 h of the contro l va lues at 0 h, respect ively. 
Thus A T R A was not effective. 
Characterization of the MSE Gene 
Half-Life of MSE mRNA. The half-life (f*) of the MSE tran-
script was determined by incubat ing the JOSK-l, N O M O - 1 
Single Gene and Gene Amplification. G e n o m i c D N A of 
the ce l l l ines JOSK-l, K G - 1 , M O B S - 1 , NB-4, N O M O - 1 , OCI-
A M L - 2 , OC I -AML-3 , PLB-985, SKM-1 , T A H R - 8 7 , THP-1 , and 
UT-7 were digested w i th the restrict ion enzymes EcoRI, 
H/ndll l or Psfl w h i c h have c leavage sites in the human MSE 
gene (16) and p robed w i th the HMSE-1 c D N A or w i th a 238-
bp fragment f rom the 5'-end (nt - 1 0 - 2 2 8 , obta ined after 
Bamhl d igest ion and extract ion f rom the gel) of the HMSE-1 
c D N A . G e n o m i c D N A f rom different ce l l l ines cut w i th the 
same e n z y m e (HindWl) showed ident ica l band ing patterns in 
Southern blots (Figure 8); the intensities of the var ious bands 
were equa l or very s imi lar in al l ce l l l ines despite the fact that 
these ce l l l ines transcr ibed quite different amounts of m R N A . 
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Figure 3 RT-PCR analysis of MSE transcripts in leukemia-lymphoma cell lines using ethidium bromide staining and hybridization after Sou-
thern blotting with the HMSE-1 c D N A probe, (a) Schematic diagram of the HMSE-1 c D N A showing the primers MSE-P1 and -P2 used for RT-
PCR detection of MSE mRNA and the primers MSE-P1 through -P4 employed for D N A sequencing, (b) Agarose gel electrophoresis of the PCR 
products (868 bp) amplified using primer pair P1/P2 in a 32-cycle PCR. Molecular size markers were run in the outside lane (denoted as 1 kb 
ladder). Lane marked H 2 0 without template RNA represents the negative control. PCR products of the same RT reaction using /3-actin primers 
were used as controls for the quality of the RNA and successful PCR amplification. The cell lines OCI-AML-3 and RW-LEU-4 are here negative 
which might have been caused by insufficient reverse transcription and/or amplification (see the weak actin band); on repeated experiments 
these two cell lines were clearly positive, (c) The products were transferred to nylon membranes by the method of Southern and hybridized 
with the HMSE-1 probe. Compare the weak expression in lymphoid cell lines (e.g. EHEB, REH) vs. the strong signals in monocytic cell lines 
(e.g. RW-LEU-4) 
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Figure 4 O v e r e x p r e s s i o n of M S E m R N A in the c e l l l i ne jOSK- l a n d the pat ient #1 in c o m p a r i s o n w i t h n o r m a l PB m o n o c y t e s (Monos ) (left). 
Pat ient #8 is c l ea r l y negat ive . The fi lter was r e h y b r i d i z e d w i t h a j3-actin c D N A p robe . Laser dens i tomet r i c s c a n n i n g a l l o w e d for quan t i f i c a t i on 
of the results (right) 
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Figure 5 O v e r e x p r e s s i o n of M S E m R N A a n d prote in in l e u k e m i a ce l l l ines . T h e intensi ty of the bands o n No r the rn blots and IEF gels we re 
measu red by laser dens i tomet r y and related to the va lues f o u n d for n o r m a l PB m o n o c y t e s (Monos ) w h i c h w e r e set as 1 0 0 % . O v e r e x p r e s s i o n 
was d e f i n e d as 2 0 0 % or h igher of the m R N A or pro te in leve ls of the M o n o s . Thus , 16/26 a n d 9/25 l e u k e m i a ce l l l ines ove rexpressed M S E 
m R N A and p ro te in , respec t i ve l y (EM-3 was m R N A + , but prote in-negat ive) . The levels of s ignals f rom dif ferent blots or gels w e r e not c o m p a r e d 
w i t h the leve ls f rom other expe r imen t s as different exposu re t imes or s ta in ing pe r iods might have been u s e d ; ins tead, pos i t i ve con t ro l standards 
(jOSK-1 and M o n o s ) w e r e i n c l u d e d to w h i c h the dens i tomet ry data w e r e re la ted . (•), m R N A ; (•), prote in 
Treatment Changes in Expression" 
Cell L\nesa 
mRNA (%) Protein (%) 
ATRA 
HL60, KG-1 
KBM-3 
MONO-MAC-6 
NB-4 
TI-1 Remained negative 
+82 
+ 241 
+427 
Remained negative 
+ 158 
+43 
+310 
TPA 
HL-60, KG-1, TI-1 
EOL-1, MONO-MAC-6, NB-4 
KBM-3 
Remained negative 
< + 25 
- 3 7 
Remained negative 
< + 25 
- 5 3 
LPS + IFN-y 
normal monocytes 
EM-3 
HL-60 
JOSK-S, ML-2, MONO-MAC-6, NB-4, THP-1, U-937 
+ 111 
- 2 5 
Remained negative 
<±25 
ND 
Remained negative 
Remained negative 
<±25 
ND, not done. 
^Cells were exposed to 10 7 M ATRA, 10 7 M TPA or 100 ng/ml LPS + 200 U/ml IFN-y; ATRA- or TPA-
treated cells were cultured for 96 h; RNA and protein of LPS-treated cells were harvested after 4 h and 
24 h, respectively. There were no changes in MSE expression in cell lines cultured continuously in their 
respective media; however, culture of normal monocytes for 96 h led to a clear downregulation of MSE 
mRNA expression. 
"Changes in MSE expression compared with the respective untreated control cells as assessed by densito-
metric scanning of the bands on the Northern blots or IEF gels. 
ATRA TPA LPS + IFN-7 
Figure 6 Express ion of M S E m R N A d u r i n g t reatment of NB-4 w i t h 1 0 " 7 M A T R A , of M O N O - M A C - 6 w i t h 10 7 M T P A , a n d of U-937 w i t h 
100 ng/ml LPS + 200 U/ml IFN-y for the t ime courses i n d i c a t e d . N o t e the M S E up regu l a t i on in NB-4 (an abou t 5-fold increase) ove r 72 h of 
ATRA-t rea tment a n d the lack of any s ign i f i can t changes in M O N O - M A C - 6 a n d U-937. Longer e x p o s u r e to LPS + IFN-y (up to 10 h) a l so d i d 
not p r o d u c e any ma jo r changes 
The fragments seen after restrict ion w i th EcoRl or H/ndll l were 
consistent w i th the gene map pub l i shed prev ious ly (16). These 
data indicate the presence of a s ingle c o p y MSE gene in the 
human genome and argue against any gene amp l i f i ca t ion as 
caus ing high MSE m R N A express ion . 
DNA Methylation. Di f ferences in D N A methy la t ion were 
dete rmined in ce l l l ines w i th different degrees of MSE 
express ion : 697 (negative in RT-PCR, Nor thern , IEF); HL-60 
(RT-PCR + , Northern- and lEF-negative); PLB-985 (RT-PCR + , 
Nor thern + , IEF + ). For Southern blots and hybr id iza t ion w i th 
the HMSE-1 probe, D N A was restricted to comp l e t i on w i th 
the methylat ion-sensit ive e n z y m e /-/pall, its insensit ive iso-
s c h i z o m e r e n z y m e Msp\ and the sensit ive e n z y m e Hha\ 
i=Cfo\). Whereas H p a l l and Hha\ cut the sequence C C G G 
on l y if the internal cy t id ine is unmethy la ted , Msp\ w i l l cut the 
same sequence irrespective of the methy la t ion status of the 
nuc leot ides . N o differential restriction patterns of HpaU, Msp\ 
or Hha\ were detected between the three ce l l l ines 6 9 7 , HL-
6 0 , and PLB-985 suggesting that demethy la t ion of cy t id ine 
residues in the sequence C p G of the MSE gene is not cor re -
lated w i th its express ion . 
Expression in Various Species. To detect sequences hom-
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Figure 7 Express ion of M S E pro te in in the NB-4 l e u k e m i a ce l l l ine e x p o s e d to 10 7 M A T R A for the t ime per iods i nd i c a t ed . Treatment of 
NB-4 ce l l s w i t h A T R A upregu la ted the M S E pro te in express ion (arrow) about 4-fold 
o logous to MSE in other organisms, Southern blot analysis of 
human , hamster, porc ine , bov ine , f ish, and insect D N A was 
per formed using H/ndll l as restriction e n z y m e and the HMSE-
1 c D N A as probe (Figure 9). W h i l e under cond i t ions of high 
str ingency a number of discrete bands were seen in al l m a m -
ma l i an samples, no hybr id iza t ion to fish or insect D N A was 
detected ind ica t ing that the MSE sequences are conserved in 
the m a m m a l i a n genomes . 
Rearrangements and Point Mutations. G i v e n the apparent 
MSE gene overexpress ion in a number of monocyte-der ived 
ce l l l ines w e used PCR-SSCP in order to detect any genomic 
gross alterations or point mutat ions. PCR-SSCP was performed 
on samples f rom normal PB monocy tes and f rom the ce l l l ines 
JOSK-l, KB-3-1, NB-4, N O M O - 1 , and U-937. The HELA-
der ivat ive ce l l l ine KB-3-1 was exam ined as w e found pre-
v ious ly that these ce l ls expressed a s igni f icant ly shorter t runc -
ated transcript (about 1.4 kb vs. norma l l y 2.0 kb) (10). The 
same migrat ion patterns of the major bands were found for 
the six samples . In the region of the m ino r bands the PB m o n o -
cytes and the KB-3-1 cel ls revealed differently migrat ing frag-
ments. To e luc idate the nature of these SSCP patterns in more 
detai l w e sequenced the c D N A obta ined by reverse t ranscr ip-
t ion using an automated sequencer and the four primers MSE-
P1 to -P4 (Figure 3a). N o point mutat ions were detected 
w i th in the first 1526 nt of the open reading frame. A c o m p a r i -
son of the sequences pub l i shed by other investigators f rom the 
l eukemia ce l l l ine U-937 (2) and a lveo lar macrophages (17) 
w i th our data showed a differential occu r rence of a nuc leot ide 
triplet in the var ious samples. This triplet encompassed nt 
8 9 2 - 8 9 4 ( C A G c o d i n g for the neutral polar a m i n o ac id 
glutamine) . W h i l e the ce l l l ine U-937 studied e lsewhere (2) 
and our KB-3-1 lacked the triplet, these nuc leot ides were pre-
sent in the a lveo lar macrophages (17), the PB monocy tes , the 
ce l l l ines JOSK-l, NB-4, N O M O - 1 , and in our U-937. 
DISCUSSION 
It has been asserted that human MSE shou ld be one of the 
few examples of a hematopoie t i c l ineage-specif ic e n z y m e (9). 
Here , w e showed that MSE express ion was indeed restricted 
to cel ls der ived from the monocy t i c l ineage at the protein and 
m R N A level w h e n using IEF and standard Northern blott ing, 
respect ively. A p p l y i n g the extremely sensit ive method of PCR, 
more than half of the l y m p h o i d l eukemia and l y m p h o m a ce l l 
l ines that were negative in the Northern analysis d i sp layed 
MSE express ion as w e l l . 
PCR-ampl i f ied products were exam ined by direct v i sua l i z -
at ion in e th id ium b romide staining after gel e lectrophores is . 
Southern blott ing, hybr id iza t ion wi th the HMSE-1 probe (thus 
con f i rm ing the speci f ic i ty of the PCR products) , and extended 
autorad iographic exposure added another order of magni tude 
of sensitivity. Thus, the use of current RT-PCR techno logy 
ref lect ing an extremely e levated level of techn ica l sensit ivity 
is necessary to detect MSE message in l y m p h o i d ce l ls . Poss-
ibly, us ing nested primers and a second round of PCR might 
show even more MSE-posit ive l y m p h o i d ce l l l ines. Despi te 
the frequent express ion of MSE by l y m p h o i d ce l l l ines, ' truly 
monocy t i c ' ce l l l ines c o u l d be readi ly d is t inguished by their 
10-50-fold higher message intensity. m R N A trace express ion 
(defined as RT-PCR + , Northern-negative) was never para l -
leled by protein express ion , at least not one that was v is ib le 
in the IEF ge l . Future studies on the regulat ion of this gene 
might e luc idate the role, if any, of MSE m R N A trace 
express ion in the absence of any signif icant protein p ro -
duc t i on . 
The lack of MSE protein or m R N A (Northern) express ion in 
some monocyte-der ived ce l l l ines and pr imary samples might 
be exp l a i ned as f o l l ows : (i) an inher i table monocy te esterase 
de f i c i ency w i th an autosomal dominan t m o d e of transmission 
has been reported recently; the inc idences were 0 . 8 % , 1 .7% , 
and 3 . 9 % for normal ind iv idua ls and for patients wi th either 
non-mal ignant or mal ignant diseases, respectively (18); (ii) a 
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Figure 8 Res t r i c t ion pattern of the M S E gene in h igh m o l e c u l a r 
we igh t D N A iso la ted f r om severa l M S E m R N A - p o s i t i v e a n d -negative 
l e u k e m i a c e l l l ines . Af ter e n d o n u c l e a s e d iges t ion w i t h HindUl the 
D N A fragments w e r e separated by pu l s ed f i e ld gel e l e c t rophores i s , 
Southern b lo t ted , a n d h y b r i d i z e d to the HMSE-1 p r o b e . T h e s izes of 
the bands are spec i f i ed in the f igure . The bands f rom al l c e l l l ines 
have a p p r o x i m a t e l y the s ame intens i ty ; there w e r e no gross a l terat ions 
of the restr ic t ion patterns 
misdiagnos is (i.e. acute mye lo i d l eukemia w i thout a m o n o -
cyt ic c o m p o n e n t vs. acute mye lomonocy t i c /monocy t i c 
leukemia) of the cases f rom w h i c h the con t inuous ce l l l ines 
had been establ ished and of our fresh l eukemia samples c a n -
not be ent irely e x c l u d e d ; regarding our pr imary l eukemia 
spec imens the e l ig ib i l i t y cr i ter ia i n c luded on l y cases that were 
C D 1 4 + and be longed morpho log i c a l l y to the FAB categories 
M 4 or M 5 ; w i th regard to the ce l l l ines w e were left to rely on 
the or ig ina l pub l i ca t ions deta i l ing the features of the seeding 
mater ia l ; (iii) some ce l l l ines appear to have lost character ist ic 
features still f ound on the or ig ina l ce l ls , e.g. most con t inuous 
monocyte-der ived ce l l l ines are no longer C D 1 4 + despite 
strong express ion of this surface marker on the init ial p o p u -
lat ion (12); s ignif icant dif ferences between ce l l l ines and the 
respect ive pr imary ce l ls were reported for other surface ant i -
gens, mo rpho log i c a l appearance , etc. (11); (iv) this 'dediffer-
ent ia t ion ' du r ing the establ ishment of the ce l l l ines might have 
led to an arrest at a more immature stage of di f ferent iat ion 
and some of the freshly exp lanted l eukemic ce l ls might cor re -
spond to rather immature norma l counterparts ; it w i l l be inter-
esting to assign by in situ hybr id iza t ion the precise stage of 
di f ferent iat ion ( C F U - M , monoblas t , p romonocy te , monocyte ) 
at w h i c h the ce l ls begin to transcr ibe the MSE gene phys io -
log ica l l y . Prev ious studies detected the MSE IEF band in 
90/146 (62% ) pr imary M 4 and M 5 cases ( rev iewed in (3)) 
w h i c h is s imi lar to the inc idences found here, i.e. 11/14 
(78% ) at the prote in and 14/20 (70%) at the m R N A level , 
respect ively . 
In a series of exper iments w e sought to determine whether 
the MSE protein and m R N A express ion c o u l d be modu la ted 
in several ce l l l ines us ing a panel of pha rmaco log i ca l and 
phys io log i ca l b ioregulators, i.e. the P K C activators T P A and 
Bryo 1, the vitamin analogues A T R A and D 3 , and LPS+ IFN-y. 
The results can be s u m m a r i z e d as f o l l ows : (i) none of these 
reagents c o u l d induce protein or m R N A express ion in any of 
the MSE-negative ce l l l ines; (ii) A T R A upregulated MSE tran-
scr ipt ion and protein synthesis in posi t ive ce l l l ines; (iii) 
neither TPA or Bryo 1 had significant effects; (iv) LPS+ IFN-y 
st imulated MSE express ion in norma l PB monocy tes , but d id 
not cause s ignif icant changes in gene express ion in some 
seven ce l l l ines. Further studies on the effect of A T R A on MSE 
express ion w i l l no doubt be informat ive w i th respect to the 
regulatory mechan i sms of this gene. 
As d o c u m e n t e d prev ious ly , there is a cons iderab le var ia -
bi l i ty in the sta ining intensities of MSE in l eukemic ce l ls (19). 
The compa r i son of bands f rom norma l PB monocy te p o p u -
lations w i th laser dens i tometr ic scann ing showed that a cer -
tain percentage of the monocy t i c l eukemia samples expressed 
increased levels of this i soenzyme . W e extended these obser -
vat ions at the m R N A and protein leve l ; Nor thern blot analysis 
con f i rmed that steady-state levels of MSE transcripts were 
elevated relative to normal monocy tes (in 1 4 % and 6 2 % of 
the pr imary and con t inuous l y cu l tured leukemias , 
respect ively) ; IEF showed that a large fract ion of MSE-posit ive 
leukemias were d is t ingu ished, in quanti tat ive terms, by an 
ove rabundance of MSE prote in (in 2 7 % and 3 6 % of the in 
vivo and in vitro l eukemias , respectively) . As all the e n z y m e 
extracts were prepared f rom the same number of ce l ls and as 
ident ica l quantit ies of total R N A were ana l yzed , c lear ly an 
overexpress ion of the MSE gene appears to occu r . 
To determine whether g e n o m i c alterations might be respon-
s ible for high express ion , genomi c D N A of negative ce l l l ines 
and ce l l l ines express ing normal or overabundant levels of 
MSE were subjected to Sothern blot analys is . N o gross alter-
at ions of the MSE gene were detected in these samples , a rgu-
ing against a poss ib le amp l i f i ca t ion or rearrangement of the 
gene and suggesting, instead, increased express ion of a struc-
tural ly unaltered gene. Ana lys i s of MSE genomi c D N A , reverse 
t ranscr ibed D N A , m R N A , and protein revealed ident ica l ly 
s ized bands and the same isoelectr ic points, respect ively, for 
al l normal and fresh or cu l tured mal ignant ce l ls ind ica t ing that 
any abnormal i t i es d id not result f rom differences in the gross 
D N A , R N A , or protein structures. 
Then , a two-step strategy based on PCR-SSCP and PCR-
directed sequenc ing was used to def ine any minute alterations 
or point mutat ions of the gene. W h i l e no point mutat ions 
c o u l d be detected in the c D N A , sequence compa r i son 
between pub l i shed data and our results unve i l ed the presence 
of a base triplet ( C A G at nt 8 9 2 - 8 9 4 c o d i n g for glutamine) in 
our normal and mal ignant spec imens and the lack of these 
nuc leot ides in the U-937 der ived HSSE-1 sequence (2) and in 
a HeLa-subc lone aberrantly express ing this gene. The s ign i f i -
c ance of this f ind ing is unc lear at the present t ime ; it might 
poss ib ly represent an insignif icant p o l y m o r p h i s m . In any 
event, in our U-937 these nuc leot ides were c lear ly present. 
Figure 9 C o n s e r v a t i o n of the M S E gene in m a m m a l i a n spec ies . G e n o m i c D N A f rom ce l l l ines of dif ferent spec ies was cut w i t h H/ndlM, s ize-
separated by agarose gel e l ec t rophores i s , Southern b lot ted and h y b r i d i z e d w i th the HMSE-1 p robe . The ce l l l ines used w e r e as f o l l o w s : A M -
C 6 S C 8 (porc ine k idney ) , BHK-21 (hamster k i d n e y ce l ls ) , D-11 ( r a inbow trout l iver) , K N R - 0 2 8 (bov ine e m b r y o n a l k idney ) , M B - 0 2 0 ( insect, 
c a b b a g e mo th larvae), O C I - A M L - 2 (human A M L M 4 ) 
Precisely what the mechanisms are that led to overabundant 
levels of MSE m R N A and protein is open to further experiments, 
but our prel iminary analysis has already exc luded some possi -
bilities. It remains to be determined whether the high proportion 
of blast cells overexpressing MSE is related to an abnormal regu-
lation of the MSE gene due to the leukemic process (possibly 
caused by alterations, e.g. point mutations, in regulatory 
elements control l ing the level of gene expression) or is triggered 
by a more physiological mechanism already present in normal 
cells. In other words, does the MSE overexpression reflect an 
abnormality or a process that is normal for a particular stage of 
monocyte differentiation or activation? 
Cross-reactivity was found wi th other m a m m a l i a n species 
suggesting that the MSE gene is evo lu t ionar i l y conserved . The 
lack of express ion in many other human ce l l types (urinary 
b ladder , k idney , breast, sk in , cerv ix , ovary, and co lon) (10) 
favors an exc lus i ve role in the hematopoie t i c system. Ana lys is 
of D N A methy la t ion of the MSE gene d id not show differential 
restriction patterns of methylat ion-sensit ive restriction 
enzymes between MSE-posit ive and -negative ce l l l ines sug-
gesting that demethy la t ion of cy t id ine residues is not cor re -
lated w i th MSE express ion . 
W h i l e a great deal of in format ion about the express ion of 
MSE has been a c cumu la t ed in the present and prev ious s tud-
ies, on l y l imi ted in format ion has been gathered about (i) the 
ce l lu la r funct ion of MSE , and (ii) its regulat ion in ce l ls . W i t h 
respect to the first issue, progress has been s low , in part 
because the phys io log i ca l substrate for this e n z y m e remains 
u n k n o w n . 
Further studies on the mechan i sms by w h i c h this gene is 
regulated shou ld lead to new insights into m o n o c y t e -
macrophage dif ferent iat ion and func t ion . Identif icat ion of 
regulators, e.g. t ranscr ipt ion factors, of the MSE gene is a 
pr ime object ive of future studies. Ove rexpress ion of this gene 
by transfect ion shou ld enab le us to p rov ide further answers 
on the up- and downregu l a t i on of MSE m R N A and prote in 
dur ing ac t iva t ion , pro l i ferat ion, and dif ferent iat ion of m o n o -
cy tes-macrophages . The next obv ious step w o u l d be to ident-
ify and charac ter ize the g e n o m i c regions for promoters and/or 
other regulatory e lements of the MSE gene ; to this end the 
thus far e lus ive 5'-region of the gene must be c l o n e d . 
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